VRTX insider buying – Vertex Pharmaceuticals Inc / Ma
5 insider purchases since 2016 worth $14.0M by 2 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2025-08-07.
Large company Public float $113.4B (latest 10-K, SEC).
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 1 older purchase (before the 5-year window) is listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| SACHS BRUCE I Director | $8.2M 3× · 35,000 sh | 2020-11-10 2025-08-06 | 8× · $38.3M last 2024-08-01 | 39,000 shares as of 2026-08-31 | Holds (sold earlier) |
| Kewalramani Reshma CEO | $5.9M 2× · 20,000 sh | 2021-08-19 2025-08-06 | 26× · $86.9M last 2026-11-06 | 105,998 shares as of 2026-03-03 | Sold part |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 0 | – | – | 46 | $93.8M |
| 2025 | 2 | $5.8M | 2 | 30 | $90.1M |
| 2024 | 0 | – | – | 51 | $89.6M |
| 2023 | 0 | – | – | 62 | $108.3M |
| 2022 | 0 | – | – | 49 | $86.9M |
| 2021 | 2 | $4.9M | 2 | 25 | $19.7M |
| 2020 | 1 | $3.3M | 1 | 93 | $219.7M |
| 2019 | 0 | – | – | 72 | $209.6M |
| 2018 | 0 | – | – | 83 | $151.5M |
| 2017 | 0 | – | – | 70 | $255.9M |
| 2016 | 0 | – | – | 65 | $39.3M |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2025-08-07 | SACHS BRUCE I | Director | 5,000 | $389.68 | $1.9M | +12.5% | SEC |
| 2025-08-07 | Kewalramani Reshma | CEO | 10,000 | $389.58 | $3.9M | +9.4% | SEC |
| 2021-08-23 | Kewalramani Reshma | CEO | 10,000 | $195.65 | $2.0M | +15.7% | SEC |
| 2021-08-04 | SACHS BRUCE I | Director | 15,000 | $197.91 | $3.0M | +57.2% | SEC |
| 2020-11-12 | SACHS BRUCE I | Director | 15,000 | $217.36 | $3.3M | +133.8% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Kewalramani Reshma | CEO & President, Director | -11,866 | $531.53 | $6.3M | Pre-planned (10b5-1) | SEC |
| 2026-07-07 | Tatsis Ourania | Officer | 1,500 | $524.99 | $787,485 | Pre-planned (10b5-1) | SEC |
| 2026-07-07 | McKechnie Duncan | Officer | 1,541 | $519.00 | $799,779 | Pre-planned (10b5-1) | SEC |
| 2026-07-06 | Liu Joy | Officer | 828 | $502.71 | $416,244 | Pre-planned (10b5-1) | SEC |
| 2026-06-30 | Bozic Carmen | Officer | 596 | $482.50 | $287,570 | Pre-planned (10b5-1) | SEC |
| 2026-06-23 | Bozic Carmen | Officer | 1,020 | $462.17 | $471,413 | Pre-planned (10b5-1) | SEC |
| 2026-06-17 | Bozic Carmen | Officer | 4,062 | $450.00 | $1.8M | Pre-planned (10b5-1) | SEC |
| 2026-06-09 | Bozic Carmen | Officer | 1,745 | $450.00 | $785,250 | Pre-planned (10b5-1) | SEC |
| 2026-06-03 | Liu Joy | Officer | 828 | $439.91 | $364,245 | Pre-planned (10b5-1) | SEC |
| 2026-06-02 | Bozic Carmen | Officer | 1,974 | $450.00 | $888,300 | Pre-planned (10b5-1) | SEC |
| 2026-05-19 | Bozic Carmen | Officer | 1,354 | $453.45 | $613,971 | Pre-planned (10b5-1) | SEC |
| 2026-05-14 | Bozic Carmen | Officer | 6,988 | $450.00 | $3.1M | Pre-planned (10b5-1) | SEC |
| 2026-05-05 | Bhatia Sangeeta N. | Director | 318 | $423.73 | $134,746 | Pre-planned (10b5-1) | SEC |
| 2026-05-05 | Liu Joy | Officer | 1,104 | $425.02 | $469,222 | Pre-planned (10b5-1) | SEC |
| 2026-04-03 | Liu Joy | Officer | 978 | $449.17 | $439,288 | Pre-planned (10b5-1) | SEC |
Showing the latest 15 of 646 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free